Trade tariffs could push Ansell to change where it makes some of its personal-protection equipment, but that doesn’t ...

上调后的42澳元目标价表明，尽管即期增长前景可能有限，但Jefferies仍认为Ansell股票的估值略高于此前水平。转向持有评级反映了考虑到预期市场条件后，对该股近期升值潜力的更谨慎展望。根据 InvestingPro 数据，公司已连续22年保持派息，当前股息收益率为1.86%，分析表明基于公允价值计算，该股略显低估。订阅者可以访问额外11个ProTips和全面的财务指标进行深入分析。

“Diversity and Equity in an Age of Denial: Actions Speak Louder Than Words” is the title of UB’s fifth annual Beyond the Knife lecture on Feb. 27. David Ansell, author of “The Death Gap: How ...

Shares climb after the company lifts its interim dividend by 34.5 per cent and announces a 184 per cent surge in net profit ...

Shareholders in Ansell (ASX:ANN) will be pleased with the H125 dividend which follows increased demand for personal ...

David Ansell, MD, author of “The Death Gap: How Inequality Kills,” is the keynote speaker. Ansell is Michael E. Kelly Presidential Professor of Internal Medicine and senior vice president/associate ...

Net ...

These shares are starting the week on a positive note. But why? The post Why Ansell, GQG, Mayne Pharma, and Star shares are ...

UBS analyst Laura Sutcliffe maintained a Hold rating on Ansell (ANSLF – Research Report) today and set a price target of A$36.00. The company’s ...

SYDNEY--Ansell shares hit a three-and-a-half-year high after the Australia-listed protective-garment manufacturer raised its earnings guidance, helped by the better-than-expected performance of its ...

The first half was hampered by higher freight costs due to port congestion and challenges with vessel availability from ...